EDGAR Filing Documents for 0001144204-16-093276

Form 8-K - Current report:

SEC Accession No. 0001144204-16-093276

Filing Date

2016-04-07

Accepted

2016-04-07 16:48:58

Documents

Period of Report

2016-04-01

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	v436300_8k.htm	8-K	43855
2	EXHIBIT 10.1	v436300_ex10-1.htm	EX-10.1	463914
3	EXHIBIT 10.2	v436300_ex10-2.htm	EX-10.2	27170
4	EXHIBIT 10.3	v436300_ex10-3.htm	EX-10.3	15408
5	EXHIBIT 10.4	v436300_ex10-4.htm	EX-10.4	15803
6	EXHIBIT 10.5	v436300_ex10-5.htm	EX-10.5	15931
7	EXHIBIT 10.6	v436300_ex10-6.htm	EX-10.6	15076
8	EXHIBIT 10.7	v436300_ex10-7.htm	EX-10.7	280962
	Complete submission text file	0001144204-16-093276.txt		879462

Mailing Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878

Business Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878 650.243.3100

KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)